Application Information

This drug has been submitted to the FDA under the reference 072687/001.

Names and composition

"FOAMICON" is the commercial name of a drug composed of ALUMINUM HYDROXIDE and MAGNESIUM TRISILICATE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
072687/001 FOAMICON ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE TABLET, CHEWABLE/ORAL 80MG and 20MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
018685/001 GAVISCON ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE TABLET, CHEWABLE/ORAL 80MG and 20MG
018685/002 GAVISCON ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE TABLET, CHEWABLE/ORAL 160MG and 40MG
071793/001 FOAMCOAT ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE TABLET, CHEWABLE/ORAL 80MG and 20MG
072687/001 FOAMICON ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE TABLET, CHEWABLE/ORAL 80MG and 20MG
089449/001 ALUMINUM HYDROXIDE AND MAGNESIUM TRISILICATE ALUMINUM HYDROXIDE; MAGNESIUM TRISILICATE TABLET, CHEWABLE/ORAL 80MG and 20MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved